Efficient Ocular Delivery of VCP siRNA via Reverse Magnetofection in RHO P23H Rodent Retina Explants

Published on Feb 6, 2021in Pharmaceutics4.421
· DOI :10.3390/PHARMACEUTICS13020225
Merve Sen2
Estimated H-index: 2
(University of Tübingen),
Marco Bassetto1
Estimated H-index: 1
+ 3 AuthorsBlanca Arango-Gonzalez18
Estimated H-index: 18
(University of Tübingen)
Sources
Abstract
The use of synthetic RNA for research purposes as well as RNA-based therapy and vaccination has gained increasing importance. Given the anatomical seclusion of the eye, small interfering RNA (siRNA)-induced gene silencing bears great potential for targeted reduction of pathological gene expression that may allow rational treatment of chronic eye diseases in the future. However, there is yet an unmet need for techniques providing safe and efficient siRNA delivery to the retina. We used magnetic nanoparticles (MNPs) and magnetic force (Reverse Magnetofection) to deliver siRNA/MNP complexes into retinal explant tissue, targeting valosin-containing protein (VCP) previously established as a potential therapeutic target for autosomal dominant retinitis pigmentosa (adRP). Safe and efficient delivery of VCP siRNA was achieved into all retinal cell layers of retinal explants from the RHO P23H rat, a rodent model for adRP. No toxicity or microglial activation was observed. VCP silencing led to a significant decrease of retinal degeneration. Reverse Magnetofection thus offers an effective method to deliver siRNA into retinal tissue. Used in combination with retinal organotypic explants, it can provide an efficient and reliable preclinical test platform of RNA-based therapy approaches for ocular diseases.
References58
Newest
#1Jinjin Jiang (CPU: China Pharmaceutical University)H-Index: 1
#2Xinru Zhang (CPU: China Pharmaceutical University)H-Index: 2
Last. Jing Chen (CPU: China Pharmaceutical University)H-Index: 6
view all 5 authors...
Age-related macular degeneration (AMD) and glaucoma are global ocular diseases with high blindness rate. RNA interference (RNAi) is being increasingly used in the treatment of these disorders with siRNA drugs, bevasiranib, AGN211745 and PF-04523655 for AMD, and SYL040012 and QPI-1007 for glaucoma. Administration routes and vectors of gene drugs affect their therapeutic effect. Compared with the non-viral vectors, viral vectors have limited payload capacity and potential immunogenicity. This revi...
14 CitationsSource
#1Blanca Arango-Gonzalez (University of Tübingen)H-Index: 18
#2Merve Sen (University of Tübingen)H-Index: 2
Last. Marius Ueffing (University of Tübingen)H-Index: 72
view all 15 authors...
Due to continuously high production rates of rhodopsin (RHO) and high metabolic activity, photoreceptor neurons are especially vulnerable to defects in proteostasis. A proline to histidine substitution at position 23 (P23H) leads to production of structurally misfolded RHO, causing the most common form of autosomal dominant Retinitis Pigmentosa (adRP) in North America. The AAA-ATPase valosin-containing protein (VCP) extracts misfolded proteins from the ER membrane for cytosolic degradation. Here...
3 CitationsSource
#1Ryan L Setten (Beckman Research Institute)H-Index: 5
#2John J. Rossi (Beckman Research Institute)H-Index: 106
Last. Si-Ping Han (California Institute of Technology)H-Index: 6
view all 3 authors...
The RNA interference (RNAi) pathway regulates mRNA stability and translation in nearly all human cells. Small double-stranded RNA molecules can efficiently trigger RNAi silencing of specific genes, but their therapeutic use has faced numerous challenges involving safety and potency. However, August 2018 marked a new era for the field, with the US Food and Drug Administration approving ONPATTRO, the first RNAi-based drug. In this Review, we discuss key advances in the design and development of RN...
333 CitationsSource
#1Simoneide Souza Titze de Almeida (UnB: University of Brasília)H-Index: 2
#2Camila Hillesheim Horst (UnB: University of Brasília)H-Index: 4
Last. Ricardo Titze de Almeida (UnB: University of Brasília)H-Index: 2
view all 5 authors...
MicroRNAs (miRNAs) regulate gene expression at posttranscriptional level by triggering RNA interference. In such a sense, aberrant expressions of miRNAs play critical roles in the pathogenesis of many disorders, including Parkinson’s disease (PD). Controlling the level of specific miRNAs in the brain is thus a promising therapeutic strategy for neuroprotection. A fundamental need for miRNA regulation (either replacing or inhibition) is a carrier capable of delivering oligonucleotides into brain ...
13 CitationsSource
#1Natsuki Monai (Hirosaki University)H-Index: 4
#2Kodai Yamauchi (Hirosaki University)H-Index: 4
Last. Mitsuru Nakazawa (Hirosaki University)H-Index: 29
view all 6 authors...
Purpose To characterize the optical coherence tomography (OCT) appearances of photoreceptor degeneration in the rhodopsin P23H transgenic rat (line 2) in relation to the histological, ultrastructural, and electroretinography (ERG) findings. Materials and methods Homozygous rhodopsin P23H transgenic albino rats (line 2, very-slow degeneration model) were employed. Using OCT (Micron IV®; Phoenix Research Labs, Pleasanton, CA, USA), the natural course of photoreceptor degeneration was recorded from...
12 CitationsSource
#1Matthew M. LaVail (UCSF: University of California, San Francisco)H-Index: 76
#2Shimpei Nishikawa (UCSF: University of California, San Francisco)H-Index: 6
Last. John G. Flannery (University of California, Berkeley)H-Index: 56
view all 13 authors...
Abstract We produced 8 lines of transgenic (Tg) rats expressing one of two different rhodopsin mutations in albino Sprague-Dawley (SD) rats. Three lines were generated with a proline to histidine substitution at codon 23 (P23H), the most common autosomal dominant form of retinitis pigmentosa in the United States. Five lines were generated with a termination codon at position 334 (S334ter), resulting in a C-terminal truncated opsin protein lacking the last 15 amino acid residues and containing al...
38 CitationsSource
#1Jagmohan Singh (Thomas Jefferson University)H-Index: 12
#2Ipsita Mohanty (Thomas Jefferson University)H-Index: 3
Last. Satish Rattan (Thomas Jefferson University)H-Index: 40
view all 3 authors...
These studies for the first time demonstrate the success of topical in vivo magnetofection (MF) of nucleic acids using perianal injections. To demonstrate its effectiveness, we used FITC-tagged siRNA via immunofluorescence microcopy and functional and biochemical evidence using miR-139-5p (which is known to target ROCK2). In conclusion, MF allows safe, convenient, efficient, and targeted delivery of oligonucleotides such as siRNAs and microRNAs. These studies have direct therapeutic implications...
8 CitationsSource
#1Ricardo Titze-de-Almeida (UnB: University of Brasília)H-Index: 12
#2Catherine DavidH-Index: 1
Last. Simoneide Souza Titze-de-Almeida (UnB: University of Brasília)H-Index: 9
view all 3 authors...
Ten years after Fire and Melo’s Nobel Prize for discovery of gene silencing by double-stranded RNA, a remarkable progress was achieved in RNA interference (RNAi). Changes in the chemical structure of synthetic oligonucleotides make them more stable and specific, and new delivery strategies became progressively available. The attention of pharmaceutical industry rapidly turned to RNAi, as an opportunity to explore new drug targets. This review addresses nine small-interfering RNAs (siRNAs) and on...
87 CitationsSource
#1Brigitte Müller (University of Giessen)H-Index: 4
#2Franziska Wagner (University of Giessen)H-Index: 2
Last. Knut Stieger (University of Giessen)H-Index: 17
view all 4 authors...
The purpose of this study was characterization of adult murine neuroretina in organ culture to investigate its suitability for use in preclinical therapeutic applications. In retinal disorders, neurodegeneration of mature retinal cells takes place. Therefore, neonatal retina cultures are not adequate for therapeutic applications, such as genome editing, as the retina is still developing with cells dividing and differentiating into highly specialized cell types such as photoreceptors.Retinal expl...
15 CitationsSource
#1Martina Giannaccini (UniPi: University of Pisa)H-Index: 8
#2Lucia Pedicini (UniPi: University of Pisa)H-Index: 1
Last. Vittoria Raffa (UniPi: University of Pisa)H-Index: 29
view all 6 authors...
Magnetic nanoparticles: a strategy to target the choroidal layer in the posterior segment of the eye
15 CitationsSource
Cited By2
Newest
#1Merve Sen (University of Tübingen)H-Index: 2
#2Oksana Kutsyr (University of Alicante)H-Index: 4
Last. Marius Ueffing (University of Tübingen)H-Index: 72
view all 6 authors...
1.Rhodopsin (RHO) misfolding mutations are a common cause of the blinding disease autosomal dominant retinitis pigmentosa (adRP). The most prevalent mutation, RHOP23H, results in its misfolding and retention in the Endoplasmic Reticulum (ER). Under homeostatic conditions, misfolded proteins are selectively identified, retained at the ER, and cleared via ER-associated degradation (ERAD) and/or autophagy. Overload of these degradation processes for a prolonged period leads to imbalanced proteostas...
Source
#1Merve Sen (University of Tübingen)H-Index: 2
#2Al-Amin M (UNIPD: University of Padua)
Last. Marius Ueffing (University of Tübingen)H-Index: 72
view all 10 authors...
1.Mutations in rhodopsin lead to its misfolding resulting in autosomal dominant retinitis pigmentosa (adRP). Pharmacological inhibition of the ATP-driven chaperone valosin- containing protein (VCP), a molecular checkpoint for protein quality control, slows down retinal degeneration in animal models. However, poor water-solubility of VCP inhibitors poses a challenge to their clinical translation as intravitreal injections for retinal treatment. In order to enable the delivery of VCP inhibitors, w...
Source